BIDWR · Tribeca Strategic Acquisition Corp.

Tribeca Strategic Acquisition Corp. exemplifies the classic SPAC structure, incorporated in October 2025 as a Cayman Islands exempted company with no operations beyond pursuing an initial business combination. The S-1/A registers a $140 million IPO of 14 million units at $10 each, each comprising one Class A ordinary share and one right to 1/10th Class A share upon deal completion. Proceeds (100.25% or $140.35M) fund a trust account invested in short-term U.S. treasuries or money market funds, yielding ~$10.025/share redemption value. The sponsor, Tribeca Strategic Partners Holdco LLC, holds 4.59M Class B founder shares bought for $10K ($0.0019/share), representing ~25% post-IPO ownership with anti-dilution protection ensuring conversion to at least 25% of post-deal shares (excluding private placements). This nominal pricing creates immediate 103% dilution at 100% redemption and incentivizes sponsor profit even if share price drops post-combination, as their shares could yield substantial upside from $0.72 breakeven.

The 21-month completion window (extendable by shareholder vote) mandates 80% fair market value test for targets, with public shareholders able to redeem up to 100% at trust NAV (subject to 15% cap per group without consent). Management's SPAC pedigree—Ramdeen led Immunovant de-SPAC, Gill on SoftBank's Better.com SPAC, Dange's XCF Global de-SPAC—positions it to source high-growth targets in AI, digital assets, clean energy. However, conflicts abound: officers/directors have fiduciary duties elsewhere, sponsor controls pre-deal voting, and non-managing investors gain economic upside via nominal founder interests without control. Financials show $0 cash and -$474K working capital deficit as of Dec 31, 2025, raising going concern doubts resolved only by IPO close.

Investor risks center on execution: no target identified, redemption could deplete trust (preventing deal if minimum cash unmet), sponsor incentives favor completion over quality. Post-deal, staggered board and Cayman governance limit shareholder recourse. Yet $140M trust provides dry powder for sizable targets, with experienced team potentially delivering value if market conditions align.